abstract objective: to compare 2 omega-3 (n-3) preparations enriched with eicosapentaenoic acid (epa) versus docosahexaenoic acid (dha) as monotherapy for major depressive disorder (mdd) in a 2-site, placebo-controlled, randomized, double-blind clinical trial.